MultiCare Valley Hospital
12606 East Mission Ave, Spokane Valley, WA · Multicare · · NPI 1538345251
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj for mammo ductogram CPT 19030 | not published | not published | $205.44 – $217.53 | 5 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $3.06 | 12 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $243.82 – $1,747.34 | 14 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $2.79 – $9.08 | 3 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $12.55 – $108.23 | 14 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $13.66 – $75.55 | 12 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $71.40 – $132.60 | 2 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $11.67 – $113.48 | 8 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $122.12 – $488.30 | 12 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,867.38 – $11,709.64 | 14 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $2.83 – $8.00 | 3 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | $48.54 | $121.35 | not published | 0 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $182.67 – $739.77 | 3 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.91 – $26.26 | 12 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $68.45 – $6,255.18 | 14 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $16.50 – $52.20 | 4 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,726,149.63 – $8,347,500.00 | 10 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | not published | not published | $5.13 – $7.33 | 2 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $60.47 – $3,063.62 | 14 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $38.22 – $178.13 | 10 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $56.55 – $3,063.62 | 14 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | $92.00 | $230.00 | $205.44 – $217.53 | 5 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | $144.80 | $362.00 | $205.44 – $217.53 | 5 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | $144.80 | $362.00 | $205.44 – $217.53 | 5 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | $107.60 | $269.00 | $205.44 – $217.53 | 5 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | $75.20 | $188.00 | $205.44 – $217.53 | 5 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.54 – $1,803.79 | 14 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $5.49 – $9,141.55 | 12 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $14.16 – $60.12 | 8 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $78.41 – $4,061.20 | 14 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $21.03 – $66.84 | 3 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $3.50 – $114.59 | 10 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $79.64 – $315.73 | 14 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.20 – $0.55 | 3 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $500.20 – $2,059.77 | 12 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $580.23 – $3,792.20 | 14 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $43.66 – $163.39 | 9 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $110.92 – $803.58 | 14 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $110.92 – $803.58 | 14 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $13.07 – $6,255.18 | 14 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $50.00 – $1,137.14 | 14 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.99 – $4,061.20 | 14 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.68 – $4,061.20 | 14 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.58 – $4,061.20 | 14 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $3.20 – $12.10 | 3 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $87.66 – $388.40 | 11 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $32.49 – $4,061.20 | 14 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.35 – $2.42 | 11 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $1.08 – $3.20 | 3 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.51 – $4,061.20 | 14 |
| Inj levocarnitine per 1 gm HCPCS J1955 | $111.20 | $278.00 | $44.15 – $86.40 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.03 – $113.48 | 8 |
| Inj, levothyroxine, freskabi HCPCS J0651 | $27.44 | $68.60 | $3.99 – $57.33 | 14 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $7.20 – $60.12 | 10 |
| Inj, lidocaine w epinephrine HCPCS J2004 | $4.87 | $12.17 | not published | 0 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $21.51 – $61.14 | 3 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,275,887.97 – $7,393,500.00 | 10 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $330.80 – $1,382.93 | 12 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $23.61 – $4,061.20 | 14 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,098.95 – $13,019.59 | 11 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $295.29 – $312.66 | 5 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $50.47 – $225.66 | 10 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $13.93 – $60.12 | 6 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $121.80 – $4,061.20 | 14 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $64.78 – $1,918.00 | 13 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $805.60 – $2,240.58 | 4 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $802.47 – $3,086.08 | 12 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | $48.36 | $120.90 | not published | 0 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $3.38 – $9.35 | 2 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.19 – $109.29 | 14 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $2.31 – $6.55 | 3 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $1.80 – $2.96 | 2 |
| Inj, micafungin (par pharm) HCPCS J2247 | $1.14 | $2.84 | $0.54 – $1.78 | 3 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $42.49 – $4,061.20 | 14 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $255.85 – $4,061.20 | 14 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $26.73 – $4,061.20 | 14 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $9.29 – $23.67 | 3 |
| Inj multihance HCPCS A9577 | $11.29 | $28.20 | not published | 0 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $0.81 – $378.93 | 8 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $692.54 – $12,661.75 | 14 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | $1,290.80 | $3,227.00 | $257.76 – $2,782.76 | 14 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.19 – $9.66 | 12 |
| Inj nivolumab 2 mg hyaluron HCPCS J9289 | not published | not published | $27.80 – $118.99 | 10 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $95.49 – $12,661.75 | 13 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $383.98 – $7,680.08 | 14 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | $2,696.40 | $6,741.00 | $383.98 – $7,680.08 | 14 |
| Inj, nyposi 1 mcg HCPCS Q5148 | not published | not published | $1.00 – $2.40 | 10 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $47.04 – $201.10 | 10 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $413.94 – $3,212.34 | 6 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $36.12 – $115.39 | 12 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $58.94 – $4,258.35 | 8 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $0.62 – $2.03 | 4 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $399.32 – $1,684.46 | 12 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $5.53 – $745.99 | 9 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $4.17 – $1,137.14 | 14 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,611,405.88 – $5,181,265.51 | 10 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $30.09 – $3,063.62 | 14 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $55.81 – $134.42 | 10 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $74.52 – $6,255.18 | 14 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $601.91 – $4,061.20 | 14 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.